Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Verastem Oncology with Breakthrough Therapy for Defactinib in Ovarian Cancer

americanpharmaceuticalreviewMay 28, 2021

Tag: Verastem , Defactinib , KRAS , VS-6766 , ovarian cancer

PharmaSources Customer Service